RxDoctor Payments Data

Rebecca Miller, NP

Family · Charlotte, NCNPI 1629453949

Payments from drug & device makers

$887in general payments, 2019–2025

Across 37 payments — averaging $23.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$188
  • Abiomed$153
  • Sumitomo Pharma America, Inc.$144
  • Urogen Pharma, Inc.$89
  • Neurocrine Biosciences, Inc.$60
  • Urovant Sciences Inc$39
  • plus $214 from 9 others

What the payments were for

  • Food & beverage$86998%
  • Education$182%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$887 in reported general payments places this provider in the 65th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$124,255
Medicare patients
352
Services billed
1,336

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lupron DepotLeuprolide Acetate22$130,134
MyrbetriqMirabegron129$87,870
GemtesaVibegron41$27,976
Tamsulosin Hcl294$3,591
Bethanechol Chloride31$1,656
Finasteride156$1,601
Silodosin27$1,591
Trospium Chloride19$1,370
NitrofurantoinNitrofurantoin Macrocrystal32$1,307
Oxybutynin Chloride ErOxybutynin Chloride62$579
Alfuzosin Hcl ErAlfuzosin Hcl27$558
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst34$516
Dutasteride14$491
Oxybutynin Chloride19$307
Testosterone Cypionate15$281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$144$27,97641 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,522 family providers in North Carolina.

Other family in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →